Perfusion Disposables (Cardiovascular) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

The model discusses in detail the impact of COVID-19 on Perfusion Disposables market for the year 2020 and beyond. Increase in aging population and valvular degeneration are major driving factors of the Perfusion Disposables market. Growing prevalence of cardiovascular diseases and lifestyle changes is expected to drive market growth in forecast years. Valvular stenosis occurs when the heart valve narrows, restricting the blood flow across it. The narrowing of the valve causes the heart to work harder to supply adequate amounts of blood to the body and can cause heart failure. However, Valvular Regurgitation occurs due to leakage of blood through the valve, even when the leaflets are closed, or reverse flow of blood as the valve is closing. As a consequence, the heart supplies reduced volumes of blood. Congenital heart defects, the most common type of birth defects, disrupt the normal flow of blood through the heart. Patients suffering from coronary heart diseases (CHD), which results in insufficient blood supply to the heart, can be treated surgically through a CABG procedure. There are two basic ways of performing CABG procedures: On-pump and Off-pump CABG.

Scope

Who should buy this report?

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –

– CMO executives who must have deep understanding of the Perfusion Disposables marketplace to make strategic planning and investment decisions.

– Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

– Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Key Highlights

Competitive Assessment

Currently marketed Perfusion Disposables and evolving competitive landscape:

– Insightful review of the key industry trends.

– Annualized total Perfusion Disposables market revenue by segment and market outlooks from 2015-2030.

– Granular data on total procedures, units, average selling prices and market values by segment.

Reasons to buy

The model will enable you to:

– Understand the impact of COVID-19 on Perfusion Disposables market.

– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

– Develop business strategies by understanding the trends shaping and driving Perfusion Disposables market.

– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Perfusion Disposables market in the future.

– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.

– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

– Track device sales in the global and country-specific Perfusion Disposables market from 2015-2030.

– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Companies mentioned

Terumo Corp

Getinge AB

Medtronic plc

LivaNova PLC

Nipro Corp

Eurosets Srl

Senko Medical Instrument Manufacturing Co. Ltd.

Fabrica Zammi

Braile Biomedica Ltda

Others

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports